Literature DB >> 12699415

Gonadotropin treatment restores in vitro interleukin-1beta and tumour necrosis factor-alpha production by stimulated peripheral blood mononuclear cells from patients with idiopathic hypogonadotropic hypogonadism.

U Musabak1, E Bolu, M Ozata, C Oktenli, A Sengul, A Inal, Z Yesilova, G Kilciler, I C Ozdemir, I H Kocar.   

Abstract

In the present study, we aimed to investigate the effects of testosterone deficiency and gonadotropin therapy on the in vitro production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) by peripheral blood mononuclear cells (PBMCs) from patients with idiopathic hypogonadotropic hypogonadism (IHH) in order to elucidate the modulatory role of androgen in cytokine production. Fifteen male patients with untreated IHH and 15 age-matched healthy male subjects were enrolled in the study. Serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), free testosterone (FT), sex hormone binding globulin (SHBG), prolactin, and IL-2 and IL-4 levels were also measured. In unstimulated cultures, IL-1beta and TNF-alpha secretion were not significantly different between patient and control groups. However, after stimulation with lipopolysaccharide (LPS), secretion of IL-1beta and TNF-alpha was significantly higher in cultures from untreated patients with IHH than in control subjects. Mean FSH, LH and FT levels were significantly lower, whereas SHBG, IL-2 and IL-4 levels were significantly higher in patients with IHH compared than in controls. In patients with IHH, FT negatively affected the serum levels of IL-4 and in vitro secretion of IL-1beta and TNF-alpha. In addition, IL-2 and IL-4 affected the in vitro secretion of IL-1beta in a positive manner. Gonadotropin therapy decreased both TNF-alpha and IL-1beta in PBMCs from patients with IHH. The levels of serum IL-2 and IL-4 were also decreased by therapy. In conclusion, in the present study, gonadotropin treatment restored the in vitro production of IL-1beta and TNF-alpha by PBMCs from patients with IHH, suggesting that androgen modulates proinflammatory cytokine production, at least directly through its effects on PBMCs. It seems probable that this effect plays an important role in the immunosuppressive action of androgens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699415      PMCID: PMC1808705          DOI: 10.1046/j.1365-2249.2003.02141.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

1.  Sex hormones modulate inflammatory mediators produced by macrophages.

Authors:  P D'Agostino; S Milano; C Barbera; G Di Bella; M La Rosa; V Ferlazzo; R Farruggio; D M Miceli; M Miele; L Castagnetta; E Cillari
Journal:  Ann N Y Acad Sci       Date:  1999-06-22       Impact factor: 5.691

2.  A gender gap in autoimmunity.

Authors:  C C Whitacre; S C Reingold; P A O'Looney
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

3.  Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  N Kanda; T Tsuchida; K Tamaki
Journal:  Arthritis Rheum       Date:  1997-09

Review 4.  Sex hormones and Sjögren's syndrome.

Authors:  D A Sullivan
Journal:  J Rheumatol Suppl       Date:  1997-09

5.  Interactions between the gonadal steroids and the immune system.

Authors:  C J Grossman
Journal:  Science       Date:  1985-01-18       Impact factor: 47.728

6.  The effect of testosterone replacement treatment on immunological features of patients with Klinefelter's syndrome.

Authors:  I H Koçar; Z Yesilova; M Ozata; M Turan; A Sengül; I Ozdemir
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

7.  Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway.

Authors:  T van der Bruggen; S Nijenhuis; E van Raaij; J Verhoef; B S van Asbeck
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

8.  Steroid sex hormones regulate the release of tumor necrosis factor by macrophages.

Authors:  T C Chao; P J Van Alten; J A Greager; R J Walter
Journal:  Cell Immunol       Date:  1995-01       Impact factor: 4.868

9.  A protective role for testosterone in adjuvant-induced arthritis.

Authors:  M S Harbuz; Z Perveen-Gill; S L Lightman; D S Jessop
Journal:  Br J Rheumatol       Date:  1995-12

10.  Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production.

Authors:  H D Danenberg; G Alpert; S Lustig; D Ben-Nathan
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

View more
  11 in total

Review 1.  Immune cells have sex and so should journal articles.

Authors:  Sabra L Klein
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

2.  Protective effect of rhIL-1beta on pancreatic islets of alloxan-induced diabetic rats.

Authors:  Li-Ping Wu; Li-Hua Chen; Jin-Shan Zhang; Lan Sun; Yuan-Qiang Zhang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

3.  Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.

Authors:  Heather S L Jim; Jong Y Park; Jennifer Permuth-Wey; Maria A Rincon; Kristin M Phillips; Brent J Small; Paul B Jacobsen
Journal:  Brain Behav Immun       Date:  2012-03-28       Impact factor: 7.217

Review 4.  Sex differences in immune responses.

Authors:  Sabra L Klein; Katie L Flanagan
Journal:  Nat Rev Immunol       Date:  2016-08-22       Impact factor: 53.106

Review 5.  Testosterone deficiency, insulin resistance and the metabolic syndrome.

Authors:  Michael Zitzmann
Journal:  Nat Rev Endocrinol       Date:  2009-10-27       Impact factor: 43.330

Review 6.  The Xs and Y of immune responses to viral vaccines.

Authors:  Sabra L Klein; Anne Jedlicka; Andrew Pekosz
Journal:  Lancet Infect Dis       Date:  2010-05       Impact factor: 71.421

7.  Feminising hormone therapy reduces testicular ACE-2 receptor expression: Implications for treatment or prevention of COVID-19 infection in men.

Authors:  John M Masterson; Chau Bui; Yi Zhang; Xiaopen Yuan; Carissa Huynh; Harneet Jawanda; Wohaib Hasan; Warren Tourtellotte; Daniel Luthringer; Maurice M Garcia
Journal:  Andrologia       Date:  2021-09-13       Impact factor: 2.775

Review 8.  Are sex disparities in COVID-19 a predictable outcome of failing men's health provision?

Authors:  Tharu Tharakan; Christopher C Khoo; Aleksander Giwercman; Channa N Jayasena; Nikolaos Sofikitis; Andrea Salonia; Suks Minhas
Journal:  Nat Rev Urol       Date:  2021-11-18       Impact factor: 16.430

9.  Low sex hormone-binding globulin is associated with hypertension: a cross-sectional study in a Swedish population.

Authors:  Bledar Daka; Thord Rosen; Per Anders Jansson; Charlotte A Larsson; Lennart Råstam; Ulf Lindblad
Journal:  BMC Cardiovasc Disord       Date:  2013-04-18       Impact factor: 2.298

Review 10.  Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered.

Authors:  A Losada-García; S A Cortés-Ramírez; M Cruz-Burgos; M Morales-Pacheco; Carlos D Cruz-Hernández; Vanessa Gonzalez-Covarrubias; Carlos Perez-Plascencia; M A Cerbón; M Rodríguez-Dorantes
Journal:  Front Genet       Date:  2022-01-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.